Bioretec
-
Extremities
The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement
TAMPERE, Finland, Nov. 20, 2024 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with…
Read More » -
Spine
Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage
TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ — Bioretec updates its product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody…
Read More » -
Financial
Bioretec Ltd’s half-year report January-June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results
TAMPERE, Finland, Aug. 15, 2024 /PRNewswire/ — This announcement is a summary of Bioretec Ltd’s half-year report January-June 2024. The complete half-year report…
Read More » -
Extremities
Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures
TAMPERE, Finland, June 19, 2024 /PRNewswire/ — Bioretec Ltd., a pioneer in biodegradable orthopedic implants, is pleased to announce that a number of…
Read More » -
Financial
Bioretec Ltd’s business review January-March 2024: Controlled launch in the U.S. progresses
TAMPERE, Finland, May 16, 2024 /PRNewswire/ — This announcement summarizes Bioretec Ltd’s business review for January-March 2024. The complete business review is attached…
Read More » -
Financial
Bioretec Ltd’s Annual Report and Financial Statements 2023 published
Bioretec Ltd Company announcement 15 March 2024 at 5:30 p.m. EET TAMPERE, Finland, March 15, 2024 /PRNewswire/ — Bioretec Ltd has today published its 2023…
Read More » -
Financial
Bioretec Ltd’s financial statements bulletin 2023: Another successful year in the growth trajectory
Bioretec Ltd Company announcement 16 February 2024 – TAMPERE, Finland, Feb. 16, 2024 /PRNewswire/ — This announcement is a summary of Bioretec Ltd’s financial statements…
Read More » -
Financial
CORRECTION: Bioretec Ltd’s Board of Directors has decided on a new option program 2023-1
TAMPERE, Finland, Oct. 20, 2023 /PRNewswire/ — “CORRECTION: Bioretec Ltd corrects the company announcement published today, 20 October 2023, at 1 p.m. There was an…
Read More » -
Extremities
Inside information: Bioretec enters into the U.S. distribution agreement with Spartan Medical for the RemeOs™ screws
TAMPERE, Finland, Sept. 12, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, has signed a distribution…
Read More » -
Spine
Bioretec unveils its revitalized Scientific Advisory Board (SAB), focusing on driving innovations in orthopedic implants
TAMPERE, Finland, Aug. 16, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing orthopedic biodegradable implants, has refined and expanded…
Read More » -
Financial
Bioretec Ltd’s Half Year Report 2023 (unaudited): Historic achievement supported by the strong sales
TAMPERE, Finland, Aug. 11, 2023 /PRNewswire/ — This is a summary of Bioretec Ltd’s half year report 2023. The complete half year…
Read More »